A few on this forum had raised this possibility and while I didn't anticipate GSK launching an approved generic this early, it was a risk I'd started to price in but didn't expect this level of panic.
I have very little spare money but it went into ACL at 29c today. 30c = approx $60m market cap?
Let's say we only capture 15% of a $400m market in the long term now. That's still $60m revenues!!! And approx 30% of that comes back to ACL as profits - we're back to a PE of 3 and on the back of VERY conservative figures IMO.
Complete overreaction = completely oversold = opportunity IMO.
- Forums
- ASX - By Stock
- TSN
- screaming buy now
screaming buy now , page-2
Featured News
NEWS
Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
Add TSN (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable